Gilead Sciences, Inc.
$133.45
▲
0.12%
2026-04-22 10:12:13
www.gilead.com
NMS: GILD
Explore Gilead Sciences, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$165.41 B
Current Price
$133.45
52W High / Low
$157.29 / $93.37
Stock P/E
19.68
Book Value
$18.29
Dividend Yield
2.41%
ROCE
24.79%
ROE
40.66%
Face Value
—
EPS
$6.78
Exp Qtr EPS
—
Sector
Healthcare
Industry
Drug Manufacturers - General
Employees
17,000
Beta
0.4
Debt / Equity
112.92
Current Ratio
1.55
Quick Ratio
1.4
Forward P/E
14.45
Price / Sales
5.86
Enterprise Value
$188.39 B
EV / EBITDA
12.92
EV / Revenue
6.4
Rating
Buy
Target Price
$157.71
EPS Forecast (FY)
—
Pros
- Healthy return on equity.
- Efficient use of capital employed.
- Short-term liquidity looks comfortable.
- Strong operating margin profile.
- Net margin remains healthy.
- Meaningful dividend yield is available.
Cons
- Some data points may be missing or delayed because the source is not an official exchange feed.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Merck & Co., Inc. | $112.83 | 15.49 | $278.33 B | 2.9% | 20.37% | 36.88% | $125.14 / $73.31 | $21.26 |
| 2. | Medicus Pharma Ltd. | $0.34 | — | $13.54 M | — | -27863.04% | -29.81% | $8.94 / $0.29 | $-0 |
| 3. | Novartis AG | $147.76 | 20.66 | $301.93 B | 3.13% | 21.09% | 30.81% | $131 / $87.89 | $24.18 |
| 4. | Scilex Holding Company | $6.95 | — | $58.97 M | — | 55.67% | 39.83% | $34.27 / $3.6 | $-29.75 |
| 5. | Organon & Co. | $9.26 | 12.89 | $2.41 B | 0.86% | 11.7% | 30.56% | $13.24 / $5.69 | $2.89 |
| 6. | Bristol-Myers Squibb Company | $59.38 | 17.16 | $121.36 B | 4.26% | 20.6% | 40.44% | $62.89 / $42.52 | $9.07 |
| 7. | Novo Nordisk A/S | $39.12 | 10.82 | $131.02 B | 4.54% | 39.01% | 60.7% | $533.4 / $224.25 | $6.83 |
Quarterly Results
Figures shown in M / B
| Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|
| Sales | 7.92 B | 7.77 B | 7.08 B | 6.67 B | 7.57 B | — |
| Operating Profit | 2.99 B | 3.5 B | 2.72 B | 2.49 B | 2.44 B | — |
| Net Profit | 2.18 B | 3.05 B | 1.96 B | 1.31 B | 1.78 B | — |
| EPS in Rs | 1.76 | 2.46 | 1.58 | 1.06 | 1.44 | — |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 29.44 B | 28.75 B | 27.12 B | 27.28 B |
| Operating Profit | 11.7 B | 10.6 B | 8.84 B | 10.97 B |
| Net Profit | 8.51 B | 480 M | 5.67 B | 4.59 B |
| EPS in Rs | 6.86 | 0.39 | 4.56 | 3.7 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 59.02 B | 58.99 B | 62.12 B | 63.17 B |
| Total Liabilities | 36.41 B | 39.75 B | 39.38 B | 41.96 B |
| Equity | 22.7 B | 19.33 B | 22.83 B | 21.24 B |
| Current Assets | 18.34 B | 19.17 B | 16.09 B | 14.44 B |
| Current Liabilities | 11.81 B | 12 B | 11.28 B | 11.24 B |
Cash Flow
Last available yearly cash flow history
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Operating CF | 10.02 B | 10.83 B | 8.01 B | 9.07 B |
| Investing CF | -4.79 B | -3.45 B | -2.27 B | -2.47 B |
| Financing CF | -7.75 B | -3.43 B | -5.12 B | -6.47 B |
| Free CF | 9.46 B | 10.3 B | 7.42 B | 8.34 B |
| Capex | -563 M | -523 M | -585 M | -728 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue Growth % | 2.39% | 6.04% | -0.6% | — |
| Earnings Growth % | 1672.92% | -91.53% | 23.37% | — |
| Profit Margin % | 28.9% | 1.67% | 20.89% | 16.83% |
| Operating Margin % | 39.74% | 36.85% | 32.59% | 40.23% |
| Gross Margin % | 78.83% | 78.26% | 76.04% | 79.26% |
| EBITDA Margin % | 46.12% | 15.42% | 38.71% | 32.45% |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
| Ex Date | Dividend |
|---|---|
| 2026-03-13 | $0.82 |
| 2025-12-15 | $0.79 |
| 2025-09-15 | $0.79 |
| 2025-06-13 | $0.79 |
| 2025-03-14 | $0.79 |
Stock Splits
No stock split history available.